Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > unreal

<< Previous

Bullboard Posts

Next >>

Post by 340daon Jun 16, 2023 12:58pm

341 Views

Post# 35500451

unreal

Spectral Medical's CEO is Chris Seto, appointed in Apr 2021, he has a tenure of 2.17 years. His total yearly compensation is CA$901.39K , comprised of 50.6% salary and 49.4% bonuses, including company stock and options. He directly owns 0.22% of the company’s shares, worth $113.45K. The average tenure of the management team and the board of directors is 2.2 years and 5.1 years respectively

<< Previous

Bullboard Posts

Next >>

BMO evolves InvestorLine with enhanced tools for options trading